- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07756879
Classroom Exercise Frequency and Mental Health in Medical Students
August 5, 2026 updated by: Dynamical Business and Science Society - DBSS International SAS
Promoción de la Actividad física y la Salud Mental en Estudiantes de Medicina
This 16-week, three-group, nonrandomized interventional study evaluated whether the weekly frequency of a brief classroom-based physical exercise program was associated with changes in mental health and physical activity among 105 undergraduate medical students at Universidad Tecnologica de Pereira, Colombia.
EG2 (n=35) received two exercise sessions per week, EG1 (n=37) received one session per week, and CG (n=33) received no exercise intervention.
Anxiety, depression, stress, and physical activity were assessed at baseline and after 16 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The three groups were specified prospectively in the ethics-approved protocol.
Participation was voluntary, and all participants completed written informed consent.
Academic groups were formed independently of the investigators by the university Registration and Academic Control Unit through its routine enrollment process.
Both intervention groups received the same approximately 10-minute classroom exercise program and differed only in weekly frequency.
Each session comprised a 3-minute warm-up, a 5-minute interval circuit involving large muscle groups, and a 2-minute cool-down with stretching and breathing.
Exercises varied across sessions and intensity increased progressively.
The target intensity was 5 to 7 on the modified 0-to-10 Borg scale together with a moderate Talk Test response.
Attendance was called before each session by the assigned instructor, and withdrawal during a session was recorded.
Adherence was defined as attendance at 80% or more of delivered sessions.
No adverse events were recorded.
Study Type
Interventional
Enrollment (Actual)
105
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Risaralda Department
-
Pereira, Risaralda Department, Colombia, 660003
- Faculty of Health Sciences, Universidad Tecnologica de Pereira
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Enrollment in the corresponding academic group (EG2, EG1, or CG) at Universidad Tecnologica de Pereira.
- Voluntary agreement to participate and completion of written informed consent.
Exclusion Criteria:
- Medical conditions that precluded participation in physical exercise.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EG2 - Classroom Exercise Twice Weekly
Thirty-five participants received two approximately 10-minute classroom exercise sessions per week for 16 weeks, corresponding to 32 delivered sessions.
|
Approximately 10-minute sessions comprising a 3-minute warm-up, a 5-minute interval circuit involving large muscle groups, and a 2-minute cool-down.
Exercises varied and intensity increased progressively, targeting 5 to 7 on the modified 0-to-10 Borg scale and a moderate Talk Test response.
The program required no exercise equipment.
|
|
Experimental: EG1 - Classroom Exercise Once Weekly
Thirty-seven participants received one approximately 10-minute classroom exercise session per week for 16 weeks, corresponding to 16 delivered sessions.
|
Approximately 10-minute sessions comprising a 3-minute warm-up, a 5-minute interval circuit involving large muscle groups, and a 2-minute cool-down.
Exercises varied and intensity increased progressively, targeting 5 to 7 on the modified 0-to-10 Borg scale and a moderate Talk Test response.
The program required no exercise equipment.
|
|
No Intervention: CG - Usual Classroom Activities
Thirty-three participants continued usual classroom activities and received no study exercise sessions during the 16-week period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anxiety symptom score assessed with the DASS-21 anxiety subscale
Time Frame: Baseline and post-intervention at week 16
|
Seven items are summed without doubling to obtain a raw score from 0 to 21.
Higher scores indicate greater anxiety symptom severity.
|
Baseline and post-intervention at week 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in depression symptom score assessed with the DASS-21 depression subscale
Time Frame: Baseline and post-intervention at week 16
|
Seven items are summed without doubling to obtain a raw score from 0 to 21.
Higher scores indicate greater depression symptom severity.
|
Baseline and post-intervention at week 16
|
|
Change in psychological stress score assessed with the DASS-21 stress subscale
Time Frame: Baseline and post-intervention at week 16
|
Seven items are summed without doubling to obtain a raw score from 0 to 21.
Higher scores indicate greater stress symptom severity.
|
Baseline and post-intervention at week 16
|
|
Change in total physical activity assessed with the short-form International Physical Activity Questionnaire
Time Frame: Baseline and post-intervention at week 16
|
Total physical activity is expressed as MET-minutes/week by summing walking, moderate-intensity, and vigorous-intensity activity.
Higher values indicate a greater physical activity volume.
|
Baseline and post-intervention at week 16
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jhonatan Gonzalez-Santamaria, PhD, Universidad Tecnológica de Pereira
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.
- Ruiz FJ, Garcia-Martin MB, Suarez-Falcon JC, Odriozola-Gonzalez P. The hierarchical factor structure of the Spanish version of Depression Anxiety and Stress Scale-21. Int J Psychol Psychol Ther. 2017;17(1):97-105.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 3, 2025
Primary Completion (Actual)
November 28, 2025
Study Completion (Actual)
November 28, 2025
Study Registration Dates
First Submitted
August 5, 2026
First Submitted That Met QC Criteria
August 5, 2026
First Posted (Actual)
August 11, 2026
Study Record Updates
Last Update Posted (Actual)
August 11, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTP-151-101224
- 28871 (Other Grant/Funding Number: Universidad Tecnológica de Pereira)
- 151-101224 (Other Identifier: Research Ethics Committee approval)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.